2 Amendments of Ádám KÓSA related to 2017/0004(COD)
Amendment 62 #
Proposal for a directive
Recital 7
Recital 7
(7) Trichloroethylene meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore is a carcinogen as defined in Directive 2004/37/EC. Trichloroethylene shall be identified as a genotoxic carcinogen. It is possible, on the basis of available information, including scientific and technical data, to set limit values for trichloroethylene in relation to a reference period of eight- hours time- weighted average (long-term exposure limit value)s), and to a shorter reference period (15 minutes). The Committeeof fifteen minutes time-weighted average (short-term exposure limit values). It is also identified forthat this carcinogen bears the possibility of significant uptake through the skin. It is therefore appropriate to establish long- and short-term exposure limit values for trichloroethylene in Part A of Annex III and to set out a skin notation in Part B of Annex III to that Directive 2004/37/EC indicating the possibility of significant dermal uptake. In light of evolving scientific evidence, the limit values for this substance will be kept under particularly close review.
Amendment 64 #
Proposal for a directive
Recital 8
Recital 8
(8) 4,4'-Methylenedianiline (MDA) meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore is a carcinogen as defined in Directive 2004/37/EC. It is possible, oconcluded that there is no possibility to derive a precise health-based exposure limit value for this non-threshold carcinogen. On the basis of available information, including scientific and technical data, it is still possible, however, to set a limit value for 4,4'- Methylenedianiline. The Committee without over exaggerated values by avoiding harming SMEs with limited financial assets as well as effectively protecting employees' health status and employment opportunities. It is also identified for this carcinogen the possibility of significant uptake through the skin. It is therefore appropriate to establish a limit value in Part A of Annex III for 4,4'-Methylenedianiline and to set out a skin notation in Part B of Annex III to that Directive 2004/37/EC indicating the possibility of significant dermal uptake.